Samuel R. Saks

2007

In 2007, Samuel R. Saks earned a total compensation of $1.2M as Former Chief Executive Officer at Jazz Pharmaceuticals, a 11% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$140,000
Option Awards$651,599
Salary$443,385
Other$689
Total$1,235,673

Saks received $651.6K in option awards, accounting for 53% of the total pay in 2007.

Saks also received $140K in non-equity incentive plan, $443.4K in salary and $689 in other compensation.

Rankings

In 2007, Samuel R. Saks' compensation ranked 3,491st out of 8,700 executives tracked by ExecPay. In other words, Saks earned more than 59.9% of executives.

ClassificationRankingPercentile
All
3,491
out of 8,700
60th
Division
Manufacturing
1,236
out of 3,314
63rd
Major group
Chemicals And Allied Products
234
out of 746
69th
Industry group
Drugs
127
out of 546
77th
Industry
Pharmaceutical Preparations
95
out of 364
74th
Source: SEC filing on October 23, 2009.

Saks' colleagues

We found four more compensation records of executives who worked with Samuel R. Saks at Jazz Pharmaceuticals in 2007.

2007

Robert Myers

Jazz Pharmaceuticals

President

2007

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2007

Matthew Fust

Jazz Pharmaceuticals

Chief Financial Officer

2007

Carol Gamble

Jazz Pharmaceuticals

General Counsel

In-depth

You may also like